Loading clinical trials...
Loading clinical trials...
Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.
Age
18 - 85 years
Sex
ALL
Healthy Volunteers
No
Suleyman Demirel University
Isparta, Mediterranean Region, Turkey (Türkiye)
Start Date
January 1, 2013
Primary Completion Date
September 1, 2017
Completion Date
December 1, 2026
Last Updated
May 20, 2025
390
ESTIMATED participants
N-acetyl cysteine
DRUG
Saline
DRUG
Lead Sponsor
Suleyman Demirel University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01311323